Pradaxa Side Effects Not Worth the Risk

Why put yourself at risk for potentially deadly Pradaxa side effects when the drug may have little benefit? A recent study from The Archives of Internal Medicine concluded that Pradaxa and other blood thinner drugs “provided no advantage over the placebo” for patients with acute coronary syndrome, and were “associated with a dramatic increase in major bleeding events.” In fact, the risk of excessive bleeding were increased three-fold, compared to a modest reduction of stent thrombosis and other heart problems. Patient survival did not show significant improvement after taking the blood-thinner drugs, suggesting that there is little reason for patients to expose themselves to the dangers of Pradaxa side effects.

Pradaxa received FDA approval in October 2010. It was the first new anti-coagulant drug to be introduced to the U.S. in over 50 years, marketed as an improvement to warfarin, another blood-thinner that has been on the market for decades. Both drugs can cause excessive bleeding—however, bleeding caused by warfarin may be stopped by administrating vitamin K, while Pradaxa lacks such anecdote. Dialysis can stop Pradaxa bleeding, but it is a risky treatment when patients are already experiencing severe bleeding. The FDA has received over 500 reports of deaths associated with Pradaxa use by the end of 2011.

Victims of Pradaxa side effects are filing Pradaxa lawsuits to seek some compensation for their injuries or loss. Pradaxa lawsuits allege that the drug’s manufacturer failed to adequately warn patients of its severe side effects and the lack of an antidote. Learn more on http://www.consumerinjurylawyers.com, or speak to a Pradaxa lawyer today by calling 1-877-779-1414.